Ergoteles LLC Aspira Women'S Health Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.32 - $0.58 $33,314 - $60,382	-104,108 Reduced 77.13%	30,869 $11,000
Q4 2022 Feb 14, 2023	SELL	$0.3 - $0.41 $46,016 - $62,889	-153,389 Reduced 53.19%	134,977 $44,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $1.07 $26,194 - $73,759	-68,934 Reduced 19.29%	288,366 $107,000
Q2 2022 Aug 12, 2022	BUY	$0.4 - $1.09 $142,920 - $389,457	357,300 New	357,300 $210,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $3.43 $71,883 - $151,263	-44,100 Closed	0 $0

Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $88,363 - $151,796	-27,700 Reduced 38.58%	44,100 $143,000
Q2 2021 Aug 12, 2021	BUY	$4.78 - $6.84 $343,204 - $491,112	71,800 New	71,800 $404,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.